Growth Metrics

ClearPoint Neuro (CLPT) EBIT Margin (2011 - 2026)

ClearPoint Neuro recorded quarterly EBIT Margin of 69.9% in Q1 2026, down 3.29% quarter-over-quarter from 67.68% in Q4 2025, and up 273.0% year-over-year from 18.74% in Q1 2025.

ClearPoint Neuro's EBIT Margin history runs 15 years deep, the most recent figure standing at 69.9% for Q1 2026.

  • In Q1 2026, EBIT Margin rose 273.0% year-over-year to 69.9%; the TTM figure through Mar 2026 stood at 65.2% (up 206.0% YoY), while the FY2025 annual figure was 65.36%, down 249.0% from the prior year.
  • EBIT Margin came in at 69.9% for Q1 2026 at ClearPoint Neuro, down from 67.68% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 55.19% in Q1 2024 to a low of 119.85% in Q2 2023.
  • A 5-year average of 75.27% and a median of 72.53% in 2024 frame the typical range for EBIT Margin.
  • Across the five-year window, EBIT Margin plunged 3900 bps in 2023 and jumped 5973 bps in 2024, its largest moves.
  • ClearPoint Neuro's EBIT Margin stood at 86.37% in 2022, then advanced by 20 bps to 69.1% in 2023, then dropped by 5 bps to 72.53% in 2024, then gained by 7 bps to 67.68% in 2025, then declined by 3 bps to 69.9% in 2026.
  • According to Business Quant data, EBIT Margin over the past three periods registered 69.9%, 67.68%, and 59.54% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.17%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn -69.90%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -69.90%
Dec 31, 2025 -67.68%
Sep 30, 2025 -59.54%
Jun 30, 2025 -61.64%
Mar 31, 2025 -72.63%
Dec 31, 2024 -72.53%
Sep 30, 2024 -63.51%
Jun 30, 2024 -60.12%
Mar 31, 2024 -55.19%
Dec 31, 2023 -69.10%
Sep 30, 2023 -84.99%
Jun 30, 2023 -119.85%
Mar 31, 2023 -105.14%
Dec 31, 2022 -86.37%
Sep 30, 2022 -73.75%
Jun 30, 2022 -80.85%
Mar 31, 2022 -76.80%
Dec 31, 2021 -92.99%
Sep 30, 2021 -83.17%
Jun 30, 2021 -99.82%
Mar 31, 2021 -54.12%
Dec 31, 2020 -60.95%
Sep 30, 2020 -36.15%
Jun 30, 2020 -59.52%
Mar 31, 2020 -38.80%
Dec 31, 2019 18.89%
Sep 30, 2019 -31.10%
Jun 30, 2019 -49.61%
Mar 31, 2019 -39.32%
Dec 31, 2018 -43.01%
Sep 30, 2018 -66.75%
Jun 30, 2018 -99.37%
Mar 31, 2018 -87.91%
Sep 30, 2016 -105.77%
Jun 30, 2016 -192.69%
Mar 31, 2016 -141.55%
Sep 30, 2015 -159.35%
Jun 30, 2015 -9,171.55%
Mar 31, 2015 -301.45%
Dec 31, 2014 -7,191.63%
Sep 30, 2014 -445.03%
Jun 30, 2014 -191.90%
Mar 31, 2014 266.50%
Dec 31, 2013 77.40%
Sep 30, 2013 -6,558.67%
Jun 30, 2013 -437.96%
Mar 31, 2013 -887.99%
Dec 31, 2012 -10.36%
Sep 30, 2012 -89.86%
Jun 30, 2012 -336.74%
Mar 31, 2012 -1,062.90%
Dec 31, 2011 -290.87%
Sep 30, 2011 -123.88%
Jun 30, 2011 -2,019.63%
Mar 31, 2011 -219.97%